CC-93269 (EngMab) is a humanized 2 + 1 IgG1-based T cell engager that binds to BCMA in myeloma cells and to CD3ε on T cells and has been shown to induce tumor regression in MM preclinical models [108]. This evidence concerns the gene TNFRSF17 and Miyoshi myopathy.